 Robert Ryu
Concepts (498)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Vena Cava Filters | 24 | 2023 | 61 | 6.550 |
Why?
| | Embolization, Therapeutic | 44 | 2020 | 229 | 3.360 |
Why?
| | Liver Neoplasms | 60 | 2014 | 786 | 3.260 |
Why?
| | Device Removal | 18 | 2023 | 136 | 3.220 |
Why?
| | Yttrium Radioisotopes | 40 | 2020 | 57 | 2.900 |
Why?
| | Portasystemic Shunt, Transjugular Intrahepatic | 10 | 2021 | 44 | 2.850 |
Why?
| | Carcinoma, Hepatocellular | 41 | 2014 | 362 | 2.570 |
Why?
| | Radiology, Interventional | 6 | 2024 | 33 | 2.510 |
Why?
| | Pulmonary Embolism | 11 | 2021 | 226 | 1.890 |
Why?
| | Radiography, Interventional | 17 | 2016 | 116 | 1.670 |
Why?
| | Esophageal and Gastric Varices | 4 | 2021 | 40 | 1.530 |
Why?
| | Chemoembolization, Therapeutic | 21 | 2014 | 91 | 1.500 |
Why?
| | Hypertension, Portal | 5 | 2016 | 64 | 1.320 |
Why?
| | Radiopharmaceuticals | 19 | 2020 | 178 | 1.320 |
Why?
| | Lumbar Vertebrae | 4 | 2021 | 246 | 1.250 |
Why?
| | Uterine Neoplasms | 11 | 2010 | 109 | 1.120 |
Why?
| | Vena Cava, Inferior | 7 | 2021 | 71 | 1.050 |
Why?
| | Educational Measurement | 2 | 2020 | 289 | 1.040 |
Why?
| | Venous Thrombosis | 6 | 2023 | 190 | 0.990 |
Why?
| | Lasers, Excimer | 2 | 2022 | 28 | 0.950 |
Why?
| | Renal Dialysis | 2 | 2020 | 435 | 0.940 |
Why?
| | Treatment Outcome | 71 | 2023 | 10811 | 0.930 |
Why?
| | Practice Patterns, Physicians' | 9 | 2021 | 1313 | 0.920 |
Why?
| | Portal Vein | 4 | 2016 | 120 | 0.900 |
Why?
| | Microspheres | 29 | 2013 | 137 | 0.890 |
Why?
| | Prosthesis Design | 7 | 2020 | 327 | 0.850 |
Why?
| | Magnetic Resonance Imaging, Interventional | 8 | 2014 | 24 | 0.820 |
Why?
| | Specialty Boards | 2 | 2020 | 36 | 0.810 |
Why?
| | Postoperative Complications | 8 | 2021 | 2654 | 0.790 |
Why?
| | Total Disc Replacement | 2 | 2020 | 14 | 0.790 |
Why?
| | Leiomyoma | 9 | 2007 | 77 | 0.780 |
Why?
| | Intervertebral Disc | 3 | 2020 | 39 | 0.770 |
Why?
| | Uterus | 7 | 2007 | 215 | 0.770 |
Why?
| | End Stage Liver Disease | 2 | 2021 | 82 | 0.750 |
Why?
| | Forecasting | 1 | 2024 | 389 | 0.750 |
Why?
| | Venous Insufficiency | 3 | 2007 | 12 | 0.720 |
Why?
| | Saphenous Vein | 3 | 2007 | 35 | 0.710 |
Why?
| | Thromboembolism | 3 | 2017 | 119 | 0.690 |
Why?
| | Middle Aged | 86 | 2023 | 33479 | 0.670 |
Why?
| | Medicare | 3 | 2020 | 773 | 0.660 |
Why?
| | Spinal Fusion | 3 | 2021 | 251 | 0.660 |
Why?
| | Humans | 151 | 2024 | 137585 | 0.650 |
Why?
| | Prosthesis Implantation | 3 | 2017 | 153 | 0.640 |
Why?
| | Intervertebral Disc Displacement | 1 | 2020 | 40 | 0.630 |
Why?
| | Laser Therapy | 3 | 2007 | 130 | 0.630 |
Why?
| | Diagnostic Imaging | 4 | 2024 | 332 | 0.630 |
Why?
| | Cerebrospinal Fluid Leak | 1 | 2020 | 62 | 0.610 |
Why?
| | Endovascular Procedures | 5 | 2020 | 312 | 0.610 |
Why?
| | Graft Occlusion, Vascular | 2 | 2018 | 40 | 0.590 |
Why?
| | Medicine | 1 | 2020 | 121 | 0.590 |
Why?
| | Magnetic Resonance Angiography | 10 | 2014 | 240 | 0.590 |
Why?
| | Low Back Pain | 1 | 2020 | 108 | 0.580 |
Why?
| | Venous Thromboembolism | 4 | 2017 | 316 | 0.570 |
Why?
| | Arteriovenous Shunt, Surgical | 1 | 2018 | 18 | 0.560 |
Why?
| | Ultrasonography, Interventional | 3 | 2016 | 141 | 0.560 |
Why?
| | Cholangiopancreatography, Endoscopic Retrograde | 3 | 2019 | 213 | 0.550 |
Why?
| | Magnetic Resonance Imaging | 27 | 2023 | 3566 | 0.540 |
Why?
| | Spine | 1 | 2019 | 173 | 0.540 |
Why?
| | Female | 102 | 2023 | 73304 | 0.540 |
Why?
| | Time Factors | 25 | 2021 | 6828 | 0.540 |
Why?
| | Product Surveillance, Postmarketing | 1 | 2017 | 63 | 0.530 |
Why?
| | Ascites | 2 | 2016 | 46 | 0.530 |
Why?
| | Gastrointestinal Hemorrhage | 4 | 2021 | 132 | 0.520 |
Why?
| | Retrospective Studies | 37 | 2023 | 15657 | 0.510 |
Why?
| | Orthopedic Procedures | 1 | 2019 | 216 | 0.510 |
Why?
| | Aged | 63 | 2021 | 23961 | 0.510 |
Why?
| | Stents | 8 | 2015 | 527 | 0.510 |
Why?
| | Tomography, X-Ray Computed | 24 | 2018 | 2691 | 0.490 |
Why?
| | Aged, 80 and over | 34 | 2021 | 7635 | 0.480 |
Why?
| | Intervertebral Disc Degeneration | 1 | 2016 | 33 | 0.480 |
Why?
| | Digestive System Neoplasms | 1 | 2015 | 9 | 0.480 |
Why?
| | Brachytherapy | 8 | 2008 | 121 | 0.470 |
Why?
| | Male | 87 | 2023 | 67762 | 0.470 |
Why?
| | Adult | 59 | 2021 | 37929 | 0.460 |
Why?
| | Cholestasis | 2 | 2015 | 235 | 0.450 |
Why?
| | Social Media | 1 | 2017 | 158 | 0.450 |
Why?
| | United States | 16 | 2024 | 14841 | 0.430 |
Why?
| | Radiation Dosage | 6 | 2020 | 179 | 0.420 |
Why?
| | Radiology | 2 | 2024 | 180 | 0.420 |
Why?
| | Thrombosis | 4 | 2022 | 371 | 0.390 |
Why?
| | Clinical Competence | 2 | 2019 | 1118 | 0.390 |
Why?
| | Liver Neoplasms, Experimental | 4 | 2020 | 31 | 0.390 |
Why?
| | Ovary | 3 | 2003 | 221 | 0.380 |
Why?
| | Angiography | 11 | 2011 | 207 | 0.360 |
Why?
| | Imaging, Three-Dimensional | 5 | 2011 | 580 | 0.360 |
Why?
| | Liver Cirrhosis | 6 | 2019 | 316 | 0.350 |
Why?
| | Risk Factors | 18 | 2020 | 10388 | 0.340 |
Why?
| | Uterine Artery Embolization | 1 | 2010 | 7 | 0.330 |
Why?
| | Vascular System Injuries | 3 | 2016 | 71 | 0.330 |
Why?
| | Cholangiocarcinoma | 4 | 2013 | 104 | 0.330 |
Why?
| | Aortic Aneurysm, Abdominal | 3 | 2007 | 140 | 0.330 |
Why?
| | Drainage | 3 | 2019 | 173 | 0.330 |
Why?
| | Perfusion Imaging | 1 | 2010 | 58 | 0.330 |
Why?
| | Endoscopy, Gastrointestinal | 3 | 2021 | 228 | 0.320 |
Why?
| | Angioplasty | 3 | 2007 | 47 | 0.320 |
Why?
| | Chicago | 6 | 2017 | 61 | 0.320 |
Why?
| | Adenoma, Islet Cell | 1 | 2009 | 8 | 0.320 |
Why?
| | Liver Abscess | 1 | 2009 | 6 | 0.320 |
Why?
| | Predictive Value of Tests | 11 | 2020 | 2031 | 0.310 |
Why?
| | Observer Variation | 3 | 2010 | 343 | 0.310 |
Why?
| | Thyroid Gland | 1 | 2009 | 94 | 0.310 |
Why?
| | Polyvinyl Alcohol | 3 | 2005 | 18 | 0.310 |
Why?
| | Neoplasms | 5 | 2023 | 2671 | 0.300 |
Why?
| | Hepatic Veins | 1 | 2008 | 33 | 0.300 |
Why?
| | Phlebography | 6 | 2015 | 38 | 0.300 |
Why?
| | Rabbits | 12 | 2020 | 794 | 0.290 |
Why?
| | Contrast Media | 12 | 2016 | 467 | 0.290 |
Why?
| | Gelatin | 2 | 2005 | 52 | 0.290 |
Why?
| | Portography | 4 | 2016 | 12 | 0.280 |
Why?
| | Neovascularization, Pathologic | 5 | 2009 | 301 | 0.280 |
Why?
| | Lymphangioma, Cystic | 1 | 2007 | 5 | 0.270 |
Why?
| | Databases, Factual | 7 | 2020 | 1357 | 0.270 |
Why?
| | Pancreatic Neoplasms | 3 | 2010 | 938 | 0.270 |
Why?
| | Patient Selection | 6 | 2020 | 696 | 0.270 |
Why?
| | Prosthesis Failure | 3 | 2017 | 123 | 0.270 |
Why?
| | Catheterization | 7 | 2013 | 179 | 0.270 |
Why?
| | Aortography | 1 | 2007 | 52 | 0.270 |
Why?
| | Liver Transplantation | 5 | 2015 | 871 | 0.270 |
Why?
| | Antineoplastic Agents | 6 | 2014 | 2129 | 0.260 |
Why?
| | Logistic Models | 8 | 2021 | 2074 | 0.260 |
Why?
| | Hepatic Artery | 5 | 2010 | 62 | 0.260 |
Why?
| | Referral and Consultation | 1 | 2012 | 786 | 0.260 |
Why?
| | Thrombolytic Therapy | 4 | 2023 | 142 | 0.260 |
Why?
| | Bile Duct Neoplasms | 4 | 2013 | 124 | 0.250 |
Why?
| | Linear Models | 4 | 2017 | 849 | 0.250 |
Why?
| | Acrylic Resins | 1 | 2005 | 46 | 0.240 |
Why?
| | Thyroid Neoplasms | 1 | 2009 | 343 | 0.240 |
Why?
| | Blood Vessel Prosthesis Implantation | 2 | 2007 | 202 | 0.230 |
Why?
| | Radiation Injuries | 5 | 2010 | 145 | 0.230 |
Why?
| | Blister | 1 | 2004 | 41 | 0.220 |
Why?
| | Internship and Residency | 2 | 2019 | 1147 | 0.220 |
Why?
| | Arteries | 7 | 2013 | 269 | 0.220 |
Why?
| | Multivariate Analysis | 7 | 2017 | 1509 | 0.210 |
Why?
| | Survival Rate | 12 | 2018 | 1972 | 0.210 |
Why?
| | Cohort Studies | 7 | 2023 | 5742 | 0.210 |
Why?
| | Postphlebitic Syndrome | 1 | 2023 | 2 | 0.200 |
Why?
| | Postthrombotic Syndrome | 1 | 2023 | 13 | 0.200 |
Why?
| | Jugular Veins | 3 | 1997 | 41 | 0.200 |
Why?
| | Neoplasm Staging | 8 | 2014 | 1389 | 0.190 |
Why?
| | Fluoroscopy | 2 | 2016 | 154 | 0.190 |
Why?
| | Prospective Studies | 16 | 2023 | 7604 | 0.190 |
Why?
| | Elasticity Imaging Techniques | 1 | 2022 | 60 | 0.190 |
Why?
| | Catheters | 3 | 2023 | 73 | 0.190 |
Why?
| | Education, Medical, Continuing | 2 | 2017 | 127 | 0.190 |
Why?
| | Kaplan-Meier Estimate | 9 | 2015 | 889 | 0.190 |
Why?
| | Clinical Trials as Topic | 3 | 2013 | 1050 | 0.190 |
Why?
| | Neoplasms, Experimental | 2 | 2013 | 176 | 0.180 |
Why?
| | Chi-Square Distribution | 6 | 2014 | 530 | 0.180 |
Why?
| | Disease Progression | 14 | 2014 | 2757 | 0.180 |
Why?
| | Multicenter Studies as Topic | 1 | 2022 | 310 | 0.180 |
Why?
| | Constriction, Pathologic | 3 | 2019 | 245 | 0.180 |
Why?
| | Vascular Patency | 3 | 2018 | 106 | 0.180 |
Why?
| | Angiography, Digital Subtraction | 6 | 2014 | 44 | 0.180 |
Why?
| | Bone-Implant Interface | 1 | 2021 | 3 | 0.180 |
Why?
| | Liver | 7 | 2013 | 1943 | 0.180 |
Why?
| | Reoperation | 4 | 2019 | 573 | 0.170 |
Why?
| | Ultrasonography, Doppler, Color | 3 | 2008 | 39 | 0.170 |
Why?
| | Medical Oncology | 2 | 2013 | 289 | 0.170 |
Why?
| | alpha-Fetoproteins | 2 | 2012 | 46 | 0.170 |
Why?
| | Catheter Ablation | 1 | 2004 | 350 | 0.170 |
Why?
| | Surgical Stomas | 1 | 2000 | 7 | 0.170 |
Why?
| | Adolescent | 16 | 2021 | 21513 | 0.170 |
Why?
| | Disease Models, Animal | 6 | 2016 | 4295 | 0.170 |
Why?
| | Colostomy | 1 | 2000 | 28 | 0.170 |
Why?
| | Liver Diseases | 2 | 2007 | 315 | 0.170 |
Why?
| | Varicose Veins | 1 | 2000 | 17 | 0.170 |
Why?
| | Infusions, Intra-Arterial | 9 | 2010 | 59 | 0.170 |
Why?
| | Sensitivity and Specificity | 9 | 2012 | 1946 | 0.170 |
Why?
| | Positron Emission Tomography Computed Tomography | 1 | 2020 | 98 | 0.160 |
Why?
| | Costs and Cost Analysis | 1 | 2020 | 213 | 0.160 |
Why?
| | Lumbosacral Region | 1 | 2020 | 58 | 0.160 |
Why?
| | Hepatorenal Syndrome | 1 | 2019 | 16 | 0.160 |
Why?
| | Budd-Chiari Syndrome | 1 | 1999 | 5 | 0.160 |
Why?
| | Hemorrhage | 2 | 2023 | 722 | 0.160 |
Why?
| | Laminoplasty | 1 | 2019 | 2 | 0.160 |
Why?
| | Follow-Up Studies | 11 | 2013 | 5131 | 0.150 |
Why?
| | Robotic Surgical Procedures | 1 | 2021 | 130 | 0.150 |
Why?
| | Laminectomy | 1 | 2019 | 31 | 0.150 |
Why?
| | Image Interpretation, Computer-Assisted | 3 | 2011 | 267 | 0.150 |
Why?
| | Bile Ducts | 1 | 2019 | 71 | 0.150 |
Why?
| | Iliac Artery | 2 | 2018 | 55 | 0.150 |
Why?
| | Specialization | 1 | 2020 | 144 | 0.150 |
Why?
| | Ohio | 1 | 2019 | 152 | 0.150 |
Why?
| | Glass | 3 | 2013 | 45 | 0.150 |
Why?
| | Young Adult | 8 | 2021 | 13209 | 0.150 |
Why?
| | Survival Analysis | 6 | 2011 | 1325 | 0.150 |
Why?
| | Models, Educational | 1 | 2019 | 93 | 0.150 |
Why?
| | Biliary Fistula | 1 | 1998 | 3 | 0.140 |
Why?
| | Urinary Fistula | 1 | 1998 | 9 | 0.140 |
Why?
| | Diffusion Magnetic Resonance Imaging | 2 | 2010 | 153 | 0.140 |
Why?
| | Intestine, Small | 1 | 2019 | 156 | 0.140 |
Why?
| | Mesenteric Veins | 1 | 1998 | 24 | 0.140 |
Why?
| | Fibrin | 2 | 2023 | 81 | 0.140 |
Why?
| | Induced Pluripotent Stem Cells | 1 | 2021 | 248 | 0.140 |
Why?
| | Pain | 1 | 2003 | 756 | 0.140 |
Why?
| | Writing | 1 | 2019 | 95 | 0.140 |
Why?
| | Thrombectomy | 1 | 1998 | 69 | 0.140 |
Why?
| | Liver Circulation | 4 | 2015 | 20 | 0.140 |
Why?
| | United States Food and Drug Administration | 2 | 2017 | 208 | 0.140 |
Why?
| | Radiography | 7 | 2012 | 822 | 0.130 |
Why?
| | Treatment Failure | 4 | 2017 | 356 | 0.130 |
Why?
| | Patient Advocacy | 1 | 2017 | 76 | 0.130 |
Why?
| | Drug Utilization | 1 | 2017 | 169 | 0.130 |
Why?
| | Hemostasis, Surgical | 1 | 2016 | 22 | 0.130 |
Why?
| | Vena Cava, Superior | 1 | 2016 | 23 | 0.130 |
Why?
| | Portal Pressure | 1 | 2016 | 4 | 0.130 |
Why?
| | Severity of Illness Index | 2 | 2021 | 2828 | 0.130 |
Why?
| | History, 20th Century | 1 | 2017 | 325 | 0.120 |
Why?
| | Hospitals | 1 | 2021 | 691 | 0.120 |
Why?
| | Anatomic Landmarks | 1 | 2016 | 29 | 0.120 |
Why?
| | Academic Medical Centers | 1 | 2019 | 512 | 0.120 |
Why?
| | Balloon Occlusion | 1 | 2016 | 34 | 0.120 |
Why?
| | Finite Element Analysis | 1 | 2016 | 75 | 0.120 |
Why?
| | Gadolinium DTPA | 5 | 2014 | 70 | 0.120 |
Why?
| | Lower Extremity | 1 | 2020 | 427 | 0.120 |
Why?
| | Doxorubicin | 3 | 2013 | 362 | 0.120 |
Why?
| | Research Design | 3 | 2013 | 1139 | 0.120 |
Why?
| | Cell Line, Tumor | 7 | 2013 | 3412 | 0.120 |
Why?
| | Patient Readmission | 1 | 2021 | 697 | 0.120 |
Why?
| | Radiation Exposure | 1 | 2016 | 49 | 0.120 |
Why?
| | Stomach | 2 | 2013 | 110 | 0.120 |
Why?
| | Reproducibility of Results | 8 | 2011 | 3284 | 0.120 |
Why?
| | Operative Time | 1 | 2016 | 145 | 0.120 |
Why?
| | Models, Anatomic | 1 | 2016 | 93 | 0.120 |
Why?
| | Aorta | 1 | 2018 | 417 | 0.120 |
Why?
| | Wounds, Nonpenetrating | 4 | 2000 | 278 | 0.120 |
Why?
| | Intraoperative Complications | 1 | 2016 | 138 | 0.120 |
Why?
| | Bile Ducts, Intrahepatic | 3 | 2013 | 78 | 0.120 |
Why?
| | Hospital Mortality | 2 | 2018 | 911 | 0.120 |
Why?
| | Necrosis | 5 | 2020 | 246 | 0.120 |
Why?
| | Dilatation | 1 | 2015 | 67 | 0.110 |
Why?
| | Sex Factors | 2 | 2018 | 2071 | 0.110 |
Why?
| | Biopsy | 3 | 2014 | 1129 | 0.110 |
Why?
| | Carotid Artery Injuries | 3 | 2000 | 41 | 0.110 |
Why?
| | Cisplatin | 3 | 2012 | 320 | 0.110 |
Why?
| | Wounds, Gunshot | 1 | 1998 | 228 | 0.110 |
Why?
| | Data Interpretation, Statistical | 3 | 2013 | 363 | 0.110 |
Why?
| | Education, Medical, Graduate | 1 | 2019 | 486 | 0.110 |
Why?
| | Foreign-Body Migration | 1 | 2014 | 34 | 0.110 |
Why?
| | Length of Stay | 2 | 2019 | 1215 | 0.110 |
Why?
| | Stress, Mechanical | 1 | 2016 | 485 | 0.110 |
Why?
| | Kidney Diseases | 1 | 1998 | 408 | 0.110 |
Why?
| | Carbon Dioxide | 1 | 2016 | 267 | 0.110 |
Why?
| | Magnetite Nanoparticles | 1 | 2013 | 30 | 0.100 |
Why?
| | Anticoagulants | 2 | 2017 | 664 | 0.100 |
Why?
| | Duodenum | 1 | 2013 | 78 | 0.100 |
Why?
| | Ultrasonography | 3 | 2022 | 759 | 0.100 |
Why?
| | Arthroscopy | 3 | 1992 | 222 | 0.100 |
Why?
| | Peripheral Arterial Disease | 1 | 2020 | 475 | 0.100 |
Why?
| | Prevalence | 3 | 2021 | 2734 | 0.100 |
Why?
| | Longitudinal Studies | 1 | 2020 | 2844 | 0.100 |
Why?
| | Catheterization, Peripheral | 3 | 2008 | 109 | 0.100 |
Why?
| | Regional Blood Flow | 3 | 2007 | 474 | 0.100 |
Why?
| | Patient Education as Topic | 1 | 2017 | 766 | 0.100 |
Why?
| | Biomechanical Phenomena | 1 | 2016 | 810 | 0.100 |
Why?
| | Proportional Hazards Models | 5 | 2014 | 1266 | 0.100 |
Why?
| | Antineoplastic Combined Chemotherapy Protocols | 2 | 2014 | 1692 | 0.100 |
Why?
| | Shoulder Injuries | 1 | 1992 | 58 | 0.100 |
Why?
| | Acromion | 1 | 1992 | 8 | 0.090 |
Why?
| | Electroporation | 1 | 2012 | 38 | 0.090 |
Why?
| | Tendon Injuries | 1 | 1992 | 68 | 0.090 |
Why?
| | Fibromuscular Dysplasia | 1 | 2011 | 7 | 0.090 |
Why?
| | Respiratory-Gated Imaging Techniques | 1 | 2011 | 10 | 0.090 |
Why?
| | Rotator Cuff | 1 | 1992 | 47 | 0.090 |
Why?
| | Animals | 15 | 2021 | 36940 | 0.090 |
Why?
| | Comorbidity | 1 | 2016 | 1622 | 0.090 |
Why?
| | Prognosis | 5 | 2010 | 4030 | 0.090 |
Why?
| | Yttrium | 1 | 2010 | 5 | 0.090 |
Why?
| | Injections, Intra-Arterial | 5 | 2012 | 27 | 0.080 |
Why?
| | Research Report | 1 | 2011 | 83 | 0.080 |
Why?
| | Tumor Burden | 3 | 2020 | 309 | 0.080 |
Why?
| | Neuroendocrine Tumors | 1 | 2011 | 116 | 0.080 |
Why?
| | Surgery, Computer-Assisted | 1 | 2011 | 101 | 0.080 |
Why?
| | Punctures | 1 | 2010 | 40 | 0.080 |
Why?
| | Practice Guidelines as Topic | 5 | 2013 | 1587 | 0.080 |
Why?
| | Biomarkers, Tumor | 3 | 2012 | 1276 | 0.080 |
Why?
| | Decision Support Techniques | 1 | 2014 | 421 | 0.080 |
Why?
| | Biopsy, Fine-Needle | 1 | 2009 | 68 | 0.080 |
Why?
| | Recurrence | 3 | 2021 | 1060 | 0.080 |
Why?
| | Gastrostomy | 2 | 2009 | 117 | 0.080 |
Why?
| | Pancreatic Pseudocyst | 1 | 2009 | 17 | 0.080 |
Why?
| | Bilirubin | 3 | 2010 | 97 | 0.080 |
Why?
| | Breast Neoplasms | 2 | 2014 | 2253 | 0.070 |
Why?
| | Ambulatory Care Facilities | 1 | 2010 | 232 | 0.070 |
Why?
| | Radiation Pneumonitis | 1 | 2008 | 29 | 0.070 |
Why?
| | Liver Function Tests | 3 | 2015 | 114 | 0.070 |
Why?
| | Palliative Care | 1 | 2015 | 758 | 0.070 |
Why?
| | Biliary Tract | 1 | 2008 | 17 | 0.070 |
Why?
| | Radiotherapy Dosage | 4 | 2010 | 268 | 0.070 |
Why?
| | Knee Injuries | 1 | 1989 | 99 | 0.070 |
Why?
| | Maximum Allowable Concentration | 1 | 2007 | 16 | 0.070 |
Why?
| | Subtraction Technique | 1 | 2007 | 23 | 0.070 |
Why?
| | Diagnosis, Differential | 3 | 2009 | 1483 | 0.070 |
Why?
| | Neoplasm Transplantation | 1 | 2008 | 257 | 0.070 |
Why?
| | Endpoint Determination | 3 | 2013 | 77 | 0.070 |
Why?
| | Vacuum Curettage | 1 | 2007 | 5 | 0.070 |
Why?
| | Diagnostic Errors | 1 | 2008 | 170 | 0.070 |
Why?
| | Acute Disease | 2 | 2021 | 1007 | 0.070 |
Why?
| | Ultrasonography, Doppler, Duplex | 2 | 2004 | 43 | 0.070 |
Why?
| | Incidence | 3 | 2009 | 2804 | 0.070 |
Why?
| | Image Enhancement | 4 | 2011 | 190 | 0.070 |
Why?
| | Radiotherapy | 1 | 2008 | 201 | 0.070 |
Why?
| | Leiomyomatosis | 1 | 2006 | 6 | 0.070 |
Why?
| | Catheterization, Central Venous | 2 | 1999 | 112 | 0.060 |
Why?
| | Credentialing | 1 | 2006 | 18 | 0.060 |
Why?
| | Hypoxia-Inducible Factor 1, alpha Subunit | 1 | 2008 | 278 | 0.060 |
Why?
| | Quality Assurance, Health Care | 1 | 2008 | 322 | 0.060 |
Why?
| | Iron | 1 | 2008 | 313 | 0.060 |
Why?
| | Fluorescent Dyes | 1 | 2007 | 321 | 0.060 |
Why?
| | Ethics, Research | 1 | 2005 | 33 | 0.060 |
Why?
| | Personnel Selection | 1 | 2006 | 78 | 0.060 |
Why?
| | Hospitalization | 3 | 2021 | 2199 | 0.060 |
Why?
| | Knee Joint | 1 | 1989 | 409 | 0.060 |
Why?
| | Decision Making | 1 | 2012 | 900 | 0.060 |
Why?
| | Organ Size | 3 | 2013 | 477 | 0.060 |
Why?
| | Postmenopause | 1 | 2007 | 366 | 0.060 |
Why?
| | Radiographic Image Interpretation, Computer-Assisted | 2 | 2020 | 110 | 0.060 |
Why?
| | Heart Failure | 1 | 2018 | 2236 | 0.060 |
Why?
| | Combined Modality Therapy | 2 | 2017 | 1236 | 0.060 |
Why?
| | Kidney Transplantation | 1 | 2011 | 708 | 0.060 |
Why?
| | Odds Ratio | 2 | 2017 | 1070 | 0.050 |
Why?
| | Dose-Response Relationship, Radiation | 3 | 2008 | 141 | 0.050 |
Why?
| | Pilot Projects | 4 | 2009 | 1710 | 0.050 |
Why?
| | Analgesia, Patient-Controlled | 1 | 2003 | 13 | 0.050 |
Why?
| | Ischemia | 1 | 2006 | 409 | 0.050 |
Why?
| | Iliac Vein | 1 | 2023 | 13 | 0.050 |
Why?
| | Illinois | 3 | 2009 | 43 | 0.050 |
Why?
| | Fellowships and Scholarships | 1 | 2006 | 306 | 0.050 |
Why?
| | Femoral Vein | 1 | 2023 | 34 | 0.050 |
Why?
| | Watchful Waiting | 1 | 2023 | 81 | 0.050 |
Why?
| | Menisci, Tibial | 2 | 1995 | 61 | 0.050 |
Why?
| | Aneurysm, False | 2 | 2000 | 48 | 0.050 |
Why?
| | Elasticity | 1 | 2022 | 197 | 0.050 |
Why?
| | Pelvis | 1 | 2002 | 102 | 0.050 |
Why?
| | Hepatectomy | 2 | 2013 | 251 | 0.040 |
Why?
| | Drug Stability | 2 | 2013 | 167 | 0.040 |
Why?
| | Colorectal Neoplasms | 1 | 2009 | 806 | 0.040 |
Why?
| | Feasibility Studies | 3 | 2011 | 956 | 0.040 |
Why?
| | Confidence Intervals | 2 | 2013 | 329 | 0.040 |
Why?
| | World Health Organization | 2 | 2012 | 123 | 0.040 |
Why?
| | X-Ray Microtomography | 1 | 2021 | 94 | 0.040 |
Why?
| | Mesenchymal Stem Cell Transplantation | 1 | 2021 | 52 | 0.040 |
Why?
| | Osseointegration | 1 | 2021 | 71 | 0.040 |
Why?
| | Allografts | 1 | 2021 | 146 | 0.040 |
Why?
| | Europe | 2 | 2012 | 414 | 0.040 |
Why?
| | Magnetic Resonance Spectroscopy | 1 | 2023 | 611 | 0.040 |
Why?
| | Administrative Claims, Healthcare | 1 | 2020 | 26 | 0.040 |
Why?
| | Mice, SCID | 1 | 2021 | 367 | 0.040 |
Why?
| | Carotid Artery, Internal | 1 | 2000 | 42 | 0.040 |
Why?
| | Neural Crest | 1 | 2021 | 118 | 0.040 |
Why?
| | Cardiologists | 1 | 2020 | 45 | 0.040 |
Why?
| | Skull | 1 | 2021 | 139 | 0.040 |
Why?
| | Disease-Free Survival | 2 | 2013 | 686 | 0.040 |
Why?
| | Radiologists | 1 | 2020 | 51 | 0.040 |
Why?
| | Bone Marrow Cells | 1 | 2021 | 316 | 0.040 |
Why?
| | Hepatic Encephalopathy | 1 | 1999 | 21 | 0.040 |
Why?
| | Ambulatory Surgical Procedures | 1 | 2020 | 66 | 0.040 |
Why?
| | Menstrual Cycle | 1 | 2000 | 133 | 0.040 |
Why?
| | Mice, Inbred NOD | 1 | 2021 | 601 | 0.040 |
Why?
| | Evidence-Based Medicine | 2 | 2013 | 740 | 0.040 |
Why?
| | Tomography, Emission-Computed | 2 | 2009 | 66 | 0.040 |
Why?
| | Tracheoesophageal Fistula | 1 | 1999 | 33 | 0.040 |
Why?
| | Anastomosis, Surgical | 1 | 2019 | 153 | 0.040 |
Why?
| | Liver Failure | 1 | 1999 | 94 | 0.040 |
Why?
| | Streptokinase | 1 | 1998 | 10 | 0.040 |
Why?
| | Serum Albumin | 1 | 1999 | 150 | 0.040 |
Why?
| | Multiple Organ Failure | 1 | 1999 | 128 | 0.040 |
Why?
| | Equipment Design | 2 | 2012 | 522 | 0.040 |
Why?
| | Analysis of Variance | 2 | 2011 | 1316 | 0.040 |
Why?
| | Postoperative Hemorrhage | 1 | 1999 | 86 | 0.040 |
Why?
| | Ethiodized Oil | 2 | 2008 | 8 | 0.040 |
Why?
| | Swine | 2 | 2016 | 775 | 0.040 |
Why?
| | Mitomycin | 2 | 2008 | 34 | 0.040 |
Why?
| | Guidelines as Topic | 2 | 2010 | 275 | 0.040 |
Why?
| | Population Surveillance | 1 | 2001 | 482 | 0.040 |
Why?
| | Nervous System Diseases | 2 | 2017 | 266 | 0.030 |
Why?
| | Cartilage Diseases | 2 | 1995 | 39 | 0.030 |
Why?
| | Intracranial Hypertension | 1 | 1997 | 40 | 0.030 |
Why?
| | Cause of Death | 1 | 1999 | 434 | 0.030 |
Why?
| | AIDS-Related Opportunistic Infections | 1 | 1997 | 127 | 0.030 |
Why?
| | Radiography, Thoracic | 1 | 1997 | 167 | 0.030 |
Why?
| | Abdominal Injuries | 1 | 1998 | 123 | 0.030 |
Why?
| | Demography | 1 | 2017 | 291 | 0.030 |
Why?
| | Tuberculosis, Pulmonary | 1 | 1997 | 141 | 0.030 |
Why?
| | Positron-Emission Tomography | 2 | 2008 | 294 | 0.030 |
Why?
| | Databases as Topic | 2 | 2010 | 67 | 0.030 |
Why?
| | Recovery of Function | 1 | 2000 | 653 | 0.030 |
Why?
| | Ambulatory Care | 1 | 2020 | 546 | 0.030 |
Why?
| | Surgeons | 1 | 2020 | 297 | 0.030 |
Why?
| | Case-Control Studies | 1 | 2003 | 3556 | 0.030 |
Why?
| | Fibrinolytic Agents | 1 | 1998 | 270 | 0.030 |
Why?
| | Lung | 1 | 2008 | 4060 | 0.030 |
Why?
| | Inpatients | 1 | 2019 | 500 | 0.030 |
Why?
| | Models, Cardiovascular | 1 | 2016 | 198 | 0.030 |
Why?
| | Phantoms, Imaging | 2 | 2008 | 152 | 0.030 |
Why?
| | Cysts | 1 | 1995 | 113 | 0.030 |
Why?
| | Hospitals, Pediatric | 1 | 2017 | 508 | 0.030 |
Why?
| | Embolism | 2 | 2008 | 41 | 0.030 |
Why?
| | Preoperative Care | 1 | 2016 | 362 | 0.030 |
Why?
| | Ablation Techniques | 1 | 2013 | 36 | 0.030 |
Why?
| | Vascular Surgical Procedures | 1 | 2016 | 303 | 0.030 |
Why?
| | Cell Differentiation | 1 | 2021 | 1991 | 0.030 |
Why?
| | Eligibility Determination | 1 | 2013 | 65 | 0.020 |
Why?
| | Radiotherapy, Adjuvant | 1 | 2013 | 220 | 0.020 |
Why?
| | Scapula | 1 | 1992 | 46 | 0.020 |
Why?
| | Nausea | 1 | 2011 | 111 | 0.020 |
Why?
| | Muscular Diseases | 1 | 1992 | 114 | 0.020 |
Why?
| | Vomiting | 1 | 2011 | 130 | 0.020 |
Why?
| | International Agencies | 1 | 2010 | 35 | 0.020 |
Why?
| | Biomarkers | 2 | 2014 | 4149 | 0.020 |
Why?
| | Clinical Trials, Phase II as Topic | 1 | 2010 | 76 | 0.020 |
Why?
| | Diarrhea | 1 | 2011 | 184 | 0.020 |
Why?
| | Abdominal Pain | 1 | 2011 | 145 | 0.020 |
Why?
| | Neoadjuvant Therapy | 1 | 2013 | 404 | 0.020 |
Why?
| | Standard of Care | 1 | 2010 | 72 | 0.020 |
Why?
| | Risk Assessment | 2 | 2009 | 3457 | 0.020 |
Why?
| | Yttrium Isotopes | 1 | 2009 | 1 | 0.020 |
Why?
| | Registries | 1 | 2018 | 2035 | 0.020 |
Why?
| | Cross-Sectional Studies | 1 | 2021 | 5472 | 0.020 |
Why?
| | Alkaline Phosphatase | 1 | 2010 | 148 | 0.020 |
Why?
| | Leukocyte Count | 1 | 2010 | 329 | 0.020 |
Why?
| | Fatigue | 1 | 2011 | 329 | 0.020 |
Why?
| | Chronic Disease | 1 | 2015 | 1793 | 0.020 |
Why?
| | Terminology as Topic | 1 | 2011 | 216 | 0.020 |
Why?
| | Range of Motion, Articular | 1 | 1992 | 393 | 0.020 |
Why?
| | Age Factors | 1 | 2017 | 3295 | 0.020 |
Why?
| | Fibula | 1 | 1989 | 43 | 0.020 |
Why?
| | Ligaments, Articular | 1 | 1989 | 51 | 0.020 |
Why?
| | ROC Curve | 1 | 2010 | 554 | 0.020 |
Why?
| | Rhenium | 1 | 2008 | 4 | 0.020 |
Why?
| | Radioisotopes | 1 | 2008 | 31 | 0.020 |
Why?
| | Iohexol | 1 | 2008 | 23 | 0.020 |
Why?
| | Body Burden | 1 | 2007 | 8 | 0.020 |
Why?
| | Hysterosalpingography | 1 | 2007 | 6 | 0.020 |
Why?
| | Tissue Distribution | 1 | 2008 | 332 | 0.020 |
Why?
| | Rats, Sprague-Dawley | 1 | 2013 | 2486 | 0.020 |
Why?
| | Tibia | 1 | 1989 | 178 | 0.020 |
Why?
| | Regression Analysis | 1 | 2010 | 1024 | 0.020 |
Why?
| | Hindlimb | 1 | 2008 | 128 | 0.020 |
Why?
| | Injections | 1 | 2008 | 183 | 0.020 |
Why?
| | Mesenteric Arteries | 1 | 2007 | 16 | 0.020 |
Why?
| | Celiac Artery | 1 | 2007 | 17 | 0.020 |
Why?
| | Equipment Failure Analysis | 1 | 2007 | 132 | 0.020 |
Why?
| | Femur | 1 | 1989 | 254 | 0.020 |
Why?
| | Contraindications | 1 | 2007 | 90 | 0.020 |
Why?
| | Injury Severity Score | 2 | 2000 | 522 | 0.020 |
Why?
| | Tumor Cells, Cultured | 1 | 2008 | 955 | 0.020 |
Why?
| | Weight Loss | 1 | 2011 | 787 | 0.020 |
Why?
| | Retreatment | 1 | 2005 | 72 | 0.010 |
Why?
| | Cartilage, Articular | 1 | 1989 | 311 | 0.010 |
Why?
| | Rats | 1 | 2013 | 5647 | 0.010 |
Why?
| | Randomized Controlled Trials as Topic | 1 | 2010 | 1477 | 0.010 |
Why?
| | Neoplasm Metastasis | 1 | 2007 | 658 | 0.010 |
Why?
| | Algorithms | 1 | 2011 | 1704 | 0.010 |
Why?
| | Mice | 1 | 2021 | 17787 | 0.010 |
Why?
| | Child, Preschool | 1 | 2017 | 11074 | 0.010 |
Why?
| | Child | 3 | 2017 | 21935 | 0.010 |
Why?
| | Radiography, Abdominal | 1 | 2001 | 45 | 0.010 |
Why?
| | Blood Flow Velocity | 1 | 2002 | 413 | 0.010 |
Why?
| | Models, Animal | 1 | 2002 | 384 | 0.010 |
Why?
| | Aorta, Abdominal | 1 | 2000 | 46 | 0.010 |
Why?
| | Arteriosclerosis | 1 | 2000 | 88 | 0.010 |
Why?
| | Pneumonia, Aspiration | 1 | 1999 | 18 | 0.010 |
Why?
| | Hematoma | 1 | 1999 | 53 | 0.010 |
Why?
| | Veins | 1 | 1999 | 63 | 0.010 |
Why?
| | Endoscopy | 1 | 2001 | 318 | 0.010 |
Why?
| | Esophageal Stenosis | 1 | 1999 | 54 | 0.010 |
Why?
| | Aortic Diseases | 1 | 2000 | 119 | 0.010 |
Why?
| | Intubation, Gastrointestinal | 1 | 1999 | 79 | 0.010 |
Why?
| | Decision Trees | 1 | 1998 | 93 | 0.010 |
Why?
| | Arm | 1 | 1999 | 104 | 0.010 |
Why?
| | Peripheral Nervous System Diseases | 1 | 1999 | 128 | 0.010 |
Why?
| | Cerebral Infarction | 1 | 1997 | 44 | 0.010 |
Why?
| | Polymorphism, Restriction Fragment Length | 1 | 1997 | 68 | 0.010 |
Why?
| | Los Angeles | 1 | 1997 | 76 | 0.010 |
Why?
| | Neurologic Examination | 1 | 1997 | 110 | 0.010 |
Why?
| | Carotid Artery Diseases | 1 | 1997 | 64 | 0.010 |
Why?
| | Intracranial Pressure | 1 | 1997 | 49 | 0.010 |
Why?
| | Multiple Trauma | 1 | 1997 | 100 | 0.010 |
Why?
| | Clinical Protocols | 1 | 1998 | 271 | 0.010 |
Why?
| | Glasgow Coma Scale | 1 | 1997 | 186 | 0.010 |
Why?
| | Enteral Nutrition | 1 | 1999 | 202 | 0.010 |
Why?
| | Carotid Stenosis | 1 | 1997 | 91 | 0.010 |
Why?
| | Angioplasty, Balloon | 1 | 1997 | 93 | 0.010 |
Why?
| | HIV | 1 | 1997 | 234 | 0.010 |
Why?
| | Carotid Arteries | 1 | 1997 | 206 | 0.010 |
Why?
| | DNA, Bacterial | 1 | 1997 | 337 | 0.010 |
Why?
| | Heparin | 1 | 1997 | 261 | 0.010 |
Why?
| | Cluster Analysis | 1 | 1997 | 499 | 0.010 |
Why?
| | Synovial Cyst | 1 | 1995 | 3 | 0.010 |
Why?
| | Craniocerebral Trauma | 1 | 1997 | 170 | 0.010 |
Why?
| | DNA, Viral | 1 | 1997 | 364 | 0.010 |
Why?
| | Mycobacterium tuberculosis | 1 | 1997 | 314 | 0.010 |
Why?
| | Brain Ischemia | 1 | 1997 | 338 | 0.010 |
Why?
| | Brain Injuries | 1 | 1997 | 494 | 0.010 |
Why?
| | Surveys and Questionnaires | 1 | 2002 | 5778 | 0.010 |
Why?
| | Tibial Meniscus Injuries | 1 | 1990 | 48 | 0.000 |
Why?
| | Postoperative Period | 1 | 1990 | 342 | 0.000 |
Why?
|
|
Ryu's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically from this person's publications. _
Co-Authors People in Profiles who have published with this person. _
Similar People People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
Physical Neighbors People whose addresses are nearby this person. _
|